ABOUT US > DEA Meetings & Events
DEA Meetings & Events
Upcoming Seminars:
Lunch & Learn Web-Series: "Strengthening Our Partnerships"
The Washington Division of the Drug Enforcement Administration (DEA) is pleased to continue their Lunch and Learn Web-Series initiative—this year under the name " Strengthening Our Partnerships". Join us every month for these 30-minute LIVE sessions where DEA speakers and Special Guests present and review information, regulations and procedures related to the proper handling, dispensing, manufacture, distribution and prescribing of Controlled Substances to prevent diversion and help reduce drug overdoses and deaths in the District of Columbia, Maryland and Virginia (DMV).
Thursday, February 23 ,2023 | 1:30PM EST | WebEx Events Platform
Topic: Diversion of Controlled Substances in Assisted Living Settings
Moderator: Justin G. Wood - Diversion Program Manager, DEA Washington Division
Speaker: Jennifer Reed - Diversion Group Supervisor, DEA Washington Division- Roanoke Resident Office
Register for Washington Division WebEx Event on February 23 ,2023
Registration is required. There is no registration fee and capacity is limited to the first 1,000 attendees. This is a LIVE event and not recorded. This program is informational and not for credit.
Any questions regarding this event may be directed to: WashingtonDiversionOutreach@dea.gov
Houston Division - Medications for Substance Use Disorder Symposium
Event Type: In Person
The Houston Division of the Drug Enforcement Administration (DEA) is pleased to present three 3.5-hour symposiums entitled "Medications for Substance Use Disorder" from 8:00 a.m. to 1:00 p.m. on the following dates and locations:
March 10, 2023 (Registration will open soon)
Edinburg Conference Center at Renaissance
118 Paseo del Prado
Edinburg, Texas 78539May 16, 2023 (Registration will open soon)
Houston Division Office
1433 W. Loop South
1st Floor Training Room
Houston, Texas 77027This symposium is designed to raise awareness of the increasing number of patients that require treatment for opioid use disorder, provide federal regulations, and resources available in Texas. The symposium will consist of various diversion topics, to include, but not limited to, "National and State Drug Trends," "Federal Regulatory Responsibilities Required by the DEA," "Opioid Use Disorder in General Medical Settings," and "Substance Use Disorder Resources Available in Texas".
See Agenda for details.
There is no registration fee for this seminar.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Texas Medical Association (TMA) through the Joint Providership of DHR Health and The US Drug Enforcement Administration. DHR Health is accredited by the TMA to provide continuing medical education for physicians. DHR Health designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Due to space limitations (200 slots per event date), registration will be on a first-come, first-served basis. Please note that any expenses you incur (including, but not limited to, travel, accommodations, parking, and meals) will be your responsibility.
Any questions regarding this conference may be directed to: DEA.Houston.OpioidSeminar@dea.gov
Conference Materials and Resources
View and download supplementary conference materials.
Past Meeting Reports and Presentations
National Conference on Pharmaceutical and Chemical Diversion
Pharmaceutical Training Seminars
Pharmacy Diversion Awareness Conference
